© 2000 by European Society of Cardiology
CASE REPORT
Prevention of recurrent ventricular fibrillation by ventricular rate stabilization
Clinical Electrophysiology Laboratory, Cardiology Division, Department of Medicine, Hospital of the Philipps-University of Marburg Marburg, Germany
This report describes a post-infarct patient with recurrent ventricular fibrillation in the absence of acute ischaemia, in whom arrhythmia recurrences could be prevented by ventricular rate stabilization of a third-generation cardioverter defibrillator. Review of the literature and clinical implications are discussed.
Key Words: Implantable defibrillator, ventricular fibrillation, rate stabilization
Correspondence: Wolfram Grimm, MD, Philipps-University Marburg, Department of Cardiology, Baldingerstrasse, 35033 Marburg, Germany.
[1] Grimm W, Flores BF, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter defibrillator therapy. Circulation 1993; 87: 1880–1888.
[2] The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576–1583.
[3] Moss AJ, Hall WJ, Cannom DS. for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933–1940.
[4] Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the ACC/AHA Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998; 31: 1175–1206.
[5] Medtronic Gem Implantable Cardioverter Defibrillator. Technical Manual. Model 7227Cx. Ref. No. 197351-036 Revision A. Minneapolis, MN: Medtronic, Inc 1998: 5–47.
[6] Berger MD, Waxmann HL, Buxton AE, Marchlinski FE, Josephson ME. Spontaneous compared with induced onset of sustained ventricular tachycardia. Circulation 1988; 78: 885–892.
[7] Bayes de Luna A, Coumel P, Leclercq J. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117: 151–159.[CrossRef][Web of Science][Medline]
[8] Gomes JA, Alexopoulos DSL, Deshmukh P, Fuster V, Suh K. The role of silent ischemia, the arrhythmic substrate and the short-long sequence in the genesis of sudden death. J Am Coll Cardiol 1989; 14: 1618–1625.[Abstract]
[9] Roelke M, Garan H, McGovern BA, Ruskin JN. Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms. J Am Coll Cardiol 1994; 23: 117–122.[Abstract]
[10] Meyerfeldt U, Schirdewan A, Wiedemann M, Schuett H, Zimmermann F, Luft FC, Dietz R. The mode of onset of ventricular tachycardia. A patient-specific phenomenon. Eur Heart J 1997; 18: 1956–1965.
[11] El-Sherif N, Gough WB, Restivo M. Reentrant ventricular arrhythmias in the late myocardial infarction period: mechanism by which a short–long–short cardiac sequence facilitates the induction of reentry. Circulation 1991; 83: 268–278.
[12] Fromer M and Wietholt D. Algorithm for the prevention of ventricular tachycardia onset: The Prevent Study. Am J Cardiol 1999; 83: 45D–47D.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||